Trial Profile
An Expanded Access Program of AvastinTM (Bevacizumab) in Patients With Metastatic Cancer of the Colon or Rectum
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Fluorouracil
- Indications Colorectal cancer
- Focus Adverse reactions
- Sponsors Roche
- 24 Oct 2015 New trial record